{"id":4392,"date":"2018-11-22T11:51:57","date_gmt":"2018-11-22T11:51:57","guid":{"rendered":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?p=4392"},"modified":"2018-11-22T11:51:57","modified_gmt":"2018-11-22T11:51:57","slug":"der-tele-pharmacist","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/","title":{"rendered":"Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention"},"content":{"rendered":"<p>AMB 2018, 52, 86\u00a0 Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention zur Verbesserung der Adh\u00e4renz war ohne Nutzen Fazit: Der \u201eTele-Pharmacist\u201c, eine komplexe, einj\u00e4hrige, individuell auf den Patienten ma\u00dfgeschneiderte Intervention durch klinische Pharmazeuten, verbesserte bei nicht ausreichend adh\u00e4renten Patienten minimal die Therapietreue. Viele Patienten schlugen das Angebot nach einiger Zeit aus, und es f\u00fchrte zu [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AMB 2018, 52, 86\u00a0 Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention zur Verbesserung der Adh\u00e4renz war ohne Nutzen Fazit: Der \u201eTele-Pharmacist\u201c, eine komplexe, einj\u00e4hrige, individuell auf den Patienten ma\u00dfgeschneiderte Intervention durch klinische Pharmazeuten, verbesserte bei nicht ausreichend adh\u00e4renten Patienten minimal die Therapietreue. Viele Patienten schlugen das Angebot nach einiger Zeit aus, und es f\u00fchrte zu [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[1434,2060,98,2063,1435,99,2062,2061,3021],"class_list":["post-4392","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-adhaerenz","tag-adherence","tag-arzneimittel","tag-arzneimittel-adhaerenz","tag-compliance","tag-medikamente","tag-nicht-adhaerenz","tag-non-adherence","tag-tele-pharmacist"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Der &quot;Tele-Pharmacist&quot;: Eine an Patienten angepasste Intervention - Der Arzneimittelbrief<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Der &quot;Tele-Pharmacist&quot;: Eine an Patienten angepasste Intervention - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"AMB 2018, 52, 86\u00a0 Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention zur Verbesserung der Adh\u00e4renz war ohne Nutzen Fazit: Der \u201eTele-Pharmacist\u201c, eine komplexe, einj\u00e4hrige, individuell auf den Patienten ma\u00dfgeschneiderte Intervention durch klinische Pharmazeuten, verbesserte bei nicht ausreichend adh\u00e4renten Patienten minimal die Therapietreue. Viele Patienten schlugen das Angebot nach einiger Zeit aus, und es f\u00fchrte zu [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-22T11:51:57+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/2_Studi_Banner_AMB_NEU.jpg\" \/>\n<meta name=\"author\" content=\"henk-amb\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"henk-amb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/\"},\"author\":{\"name\":\"henk-amb\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\"},\"headline\":\"Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention\",\"datePublished\":\"2018-11-22T11:51:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/2_Studi_Banner_AMB_NEU.jpg\",\"keywords\":[\"Adh\u00e4renz\",\"Adherence\",\"Arzneimittel\",\"Arzneimittel-Adh\u00e4renz\",\"Compliance\",\"Medikamente\",\"Nicht-Adh\u00e4renz\",\"Non-adherence\",\"Tele-Pharmacist\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/\",\"name\":\"Der \\\"Tele-Pharmacist\\\": Eine an Patienten angepasste Intervention - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/2_Studi_Banner_AMB_NEU.jpg\",\"datePublished\":\"2018-11-22T11:51:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/2_Studi_Banner_AMB_NEU.jpg\",\"contentUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2014\\\/01\\\/2_Studi_Banner_AMB_NEU.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/der-tele-pharmacist\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\",\"name\":\"henk-amb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"caption\":\"henk-amb\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Der \"Tele-Pharmacist\": Eine an Patienten angepasste Intervention - Der Arzneimittelbrief","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/","og_locale":"de_DE","og_type":"article","og_title":"Der \"Tele-Pharmacist\": Eine an Patienten angepasste Intervention - Der Arzneimittelbrief","og_description":"AMB 2018, 52, 86\u00a0 Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention zur Verbesserung der Adh\u00e4renz war ohne Nutzen Fazit: Der \u201eTele-Pharmacist\u201c, eine komplexe, einj\u00e4hrige, individuell auf den Patienten ma\u00dfgeschneiderte Intervention durch klinische Pharmazeuten, verbesserte bei nicht ausreichend adh\u00e4renten Patienten minimal die Therapietreue. Viele Patienten schlugen das Angebot nach einiger Zeit aus, und es f\u00fchrte zu [&hellip;]","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2018-11-22T11:51:57+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/2_Studi_Banner_AMB_NEU.jpg","type":"","width":"","height":""}],"author":"henk-amb","twitter_misc":{"Verfasst von":"henk-amb","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/"},"author":{"name":"henk-amb","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937"},"headline":"Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention","datePublished":"2018-11-22T11:51:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/"},"wordCount":256,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/2_Studi_Banner_AMB_NEU.jpg","keywords":["Adh\u00e4renz","Adherence","Arzneimittel","Arzneimittel-Adh\u00e4renz","Compliance","Medikamente","Nicht-Adh\u00e4renz","Non-adherence","Tele-Pharmacist"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/","name":"Der \"Tele-Pharmacist\": Eine an Patienten angepasste Intervention - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/2_Studi_Banner_AMB_NEU.jpg","datePublished":"2018-11-22T11:51:57+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937"},"breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/#primaryimage","url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/2_Studi_Banner_AMB_NEU.jpg","contentUrl":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2014\/01\/2_Studi_Banner_AMB_NEU.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/der-tele-pharmacist\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Der &#8222;Tele-Pharmacist&#8220;: Eine an Patienten angepasste Intervention"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937","name":"henk-amb","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","caption":"henk-amb"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/4392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=4392"}],"version-history":[{"count":1,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/4392\/revisions"}],"predecessor-version":[{"id":4393,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/4392\/revisions\/4393"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=4392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=4392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=4392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}